Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.

Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19

Nguemeni Tiako, M. J.

Release Date:

Summary Report/Recommendations

Policy Change/ Development
Healthcare Access and Quality
Social and Community Context
Tools Included
Outside U.S.

Mitigation and Prevention

This commentary describes racial disparities in access to medication assisted treatment (MAT) for opioid use disorder (OUD) and how pandemic-related changes in access to MAT may exacerbate these disparities. The author also provides specific recommendations, including actions that can be taken by local health departments to reduce race-based inequities in access to MAT during the pandemic.

Resource Details

Outcomes of Interest

Advancing Racial Equity, Reduction of Health Disparities

Priority Population(s)

Black or African American, Hispanic, Latino, or Latinx, People With Substance Use Disorders

Setting(s) of Implementation

Geographic Area of Implementation

Implementation Period